NFKB1 and Sepsis: Our study results imply that celecoxib is effective in controlling inflammatory response by the activation of SIRT1, inhibiting inflammatory protein COX-2, and NF-κB pathways in polymicrobial sepsis murine model and helping antibiotic in clearing the bacterial load.